Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis

Published:2021-09 Issue:9 Volume:22 Page:1265-1274
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Zhou Xiaoxiang,Yao Zhuoran,Bai Hua,Duan Jianchun,Wang Zhijie,Wang Xin,Zhang Xue,Xu Jiachen,Fei Kailun,Zhang Zhen,Tan Fengwei,Xue Qi,Gao Shugeng,Gao Yibo,Wang Jie,He Jie

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Immune checkpoint blockade in cancer therapy;Postow;J Clin Oncol,2015

2. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018

3. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015

4. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med,2015

5. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial;Rittmeyer;Lancet,2017

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders;Advanced Science;2024-09-09

2. Chemoradiotherapy plus immunotherapy for locoregionally advanced nasopharyngeal carcinoma: A cost‐effectiveness analysis;Head & Neck;2024-09-08

3. Consideration on immunotherapy of liver metastases of malignant tumors;World Journal of Gastrointestinal Surgery;2024-08-27

4. Clinical and Pathologic Response to Neoadjuvant Immunotherapy in DNA Mismatch Repair Protein-Deficient Gastroesophageal Cancers;Annals of Surgical Oncology;2024-08-17

5. Predictors of survival in immunotherapy‐based treatments in advanced melanoma: a meta‐analysis;International Journal of Dermatology;2024-08-04